Intelligent Ultrasound has sold its clinical AI business to GE HealthCare
Intelligent Ultrasound Group plc has completed the sale of its clinical AI software business to GE HealthCare for US$52.3 million. This cross-border transaction bolsters GE HealthCare’s ultrasound systems offering by enabling deeper integration of AI solutions to improve clinical workflows, reduce repetitive tasks and simplify examinations.
Intelligent Ultrasound Group plc (AIM: IUG) is one of the world’s leading classroom-to-clinic ultrasound companies, specializing in real-time, high-fidelity virtual reality simulation for the ultrasound training market and artificial intelligence-based clinical image analysis software tools for diagnostic medical ultrasound. Based in Cardiff, UK, and Atlanta, USA, the group has sold its clinical AI business comprising Intelligent Ultrasound Limited, the developer of medical ultrasound software, together with related clinical AI assets.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics and digital solutions provider, delivering integrated systems, services and data analytics to improve hospital efficiency, clinical effectiveness, therapeutic precision and patient outcomes. With more than 125 years of experience, the company advances patient care from diagnosis to therapy and monitoring, while simplifying the patient journey across the care pathway. GE HealthCare operates across imaging, ultrasound and image-guided therapies, patient care solutions and pharmaceutical diagnostics, and is a US$19.6 billion business employing approximately 51,000 people.
Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised Intelligent Ultrasound Group plc on the sale of its clinical AI business to GE HealthCare.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreGroupe JVS has acquired Abelium Collectivités
Groupe JVS has acquired Abelium Collectivités, which was subsequently rebranded as Familea. The transaction, supported by CAPZA as a minority shareholder and Bpifrance, strengthens Groupe JVS’s strategy in the childcare and family services sector while expanding its offering to local public sector stakeholders.
Learn moreGrupo Gtd has sold Gtdata to Infracorp
Gtdata, the data center platform of Gtd Grupo Teleductos S.A., has been acquired by Infracorp, the infrastructure investment platform of Grupo Romero, through the purchase of a 49% stake for US$118 million.
Learn more